TrialBMC research notes2017

Low toxicity and favorable clinical and quality of life impact after non-myeloablative autologous hematopoietic stem cell transplant in Crohn's disease.

Milton Artur Ruiz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.